Rein Therapeutics terminates Yorkville equity facility; $3M drawn, no penalties

Rein Therapeutics, Inc.

Terminated Pre-Paid Advance and Standby Equity Purchase Agreements with Yorkville on Dec 11, 2025.
Total $3M in advances drawn under PPA; most recent advance on Oct 23, 2025.
No sales of common stock executed under the Standby Equity Purchase Agreement.
No penalties or fees incurred in connection with the termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.